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a b s t r a c t 
Data on the allele and genotype frequencies of the 
three functionally significant single nucleotide polymor- 
phisms (SNPs) of the matrix metalloproteinases ( MMP ) genes 
(rs1799750 MMP1 , rs3918242 and rs17576 MMP9 ) in Russian 
patients with primary open-angle glaucoma (POAG), essen- 
tial hypertension (EH) and peptic ulcer (PU) are presented. 
Association studies identified these SNPs as possible signifi- 
cant markers associated with many multifactorial disorders, 
including POAG, EH, and PU. The frequencies of alleles and 
genotypes of the three SNPs in Russian patients with POAG, 
EH, and PU were presented separately for the entire study 
sample, females, and males, respectively. The data can be 
used as a reference for the Russian population. 
© 2020 The Author(s). Published by Elsevier Inc. 
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a  Specifications Table 
Subject Biology 
Specific subject area Genetics 
Type of data Table and figure 
How data were acquired MALDI/TOF mass spectrometry using the Sequenom MassARRAY 4.0 platform 
(Agena Bioscience TM ) 
Data format Raw and analyzed data 
Parameters for data 
collection 
Whole blood (5 ml) was drawn to a plastic vial (Vacutainer R ©) containing 0.5 M 
EDTA ( рН= 8.0). Genomic DNA was isolated by the standard phenol-chloroform 
method. DNA samples were first checked for quality (concentration 10–15 ng/mL, 
purity А260/ А280 = 1.7–2.0) and then used for genotyping. About 5% of blind 
replicate samples were used for genotyping quality control; the repeatability test 
indicated a 100% concordance rate. 
Description of data 
collection 
The quality of isolated DNA was checked by the Nanodrop-20 0 0 
spectrophotometer. Genotyping was performed on the Sequenom MassARRAY R ©
iPLEX platform using the MALDI-TOF (matrix-assisted laser desorption/ ionization 
time-of-flight) mass spectrometry. Assay Design Suite 1.0 was used to design a 
multiplex genotyping assay 
( http://agenabio.com/assay- design- suite- 10- software ) . 
Data source location Belgorod, Russia 
Data accessibility The data is available with this article 
Value of the data 
• The frequencies of alleles and genotypes of rs1799750 MMP1 , rs3918242 and rs17576 MMP9
in Russian patients with POAG, EH, and PU are presented separately for the entire cohort,
male and female participants. 
• The polymorphisms rs1799750 MMP1 , rs3918242 and rs17576 MMP9 may be associated with
POAG, EH, and PU. 
• The data on the allele and genotype frequencies of the MMP genes can be used for meta-
analyses of genetic studies on POAG, EH, and PU. 
• The presented data of the MMP genes polymorphisms can serve as a reference for population
and genetic association studies of the common disorders. 
. Data description 
The dataset contains the raw data (supplementary Table), frequencies of alleles and genotypes
 Table 1 ) for three SNPs of two MMP genes (rs1799750 MMP1 , rs3918242 and rs17576 MMP9 )
n Russian patients diagnosed with POAG, EH, and PU. These polymorphisms were previously
eported for their association with POAG, EH, and PU ( Table 2 ) [1–45] . The studied SNPs manifest
he regulatory potential ( Table 3 ), which is evidenced by several eQTLs ( Table 4 ) and splicing
TLs ( Table 5 ). The allele and genotype frequencies are provided separately for the whole study
ohort, females, and males, respectively. No significant differences in the frequencies of alleles
nd genotypes were found between the male and female participants for each of the studied
iseases. 
. Experimental design, materials, and methods 
.1. Study subjects 
The study cohort consisted of 1556 Russian participants, including 536 patients diagnosed
ith POAG (290 females and 246 males), 621 patients with EH (359 females and 262 males),
nd 399 patients with PU (211 females and 188 males). The study participants were clinically
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Table 1 
The frequencies of alleles and genotypes for SNPs rs1799750 MMP1 , rs3918242 and rs17576 MMP9 in Russian patients 




All Male Female 
n frequency n frequency n frequency 
rs1799750 
POAG 1G1G 152 0.2836 73 0.2968 79 0.2724 
1G2G 267 0.4981 131 0.5325 136 0.4690 
2G2G 117 0.2183 42 0.1707 75 0.2586 
1G 571 0.5327 277 0.5630 294 0.5069 
2G 501 0.4673 215 0.4370 286 0.4931 
rs3918242 
СС 385 0.7183 175 0.7114 210 0.7241 
СТ 133 0.2482 65 0.2642 68 0.2345 
ТТ 18 0.0335 6 0.0244 12 0.0414 
С 903 0.8424 415 0.8435 488 0.8414 
Т 169 0.1576 77 0.1565 92 0.1586 
rs17576 
AA 205 0.3825 110 0.4472 95 0.3276 
GA 260 0.4851 108 0.4390 152 0.5241 
GG 71 0.1324 28 0.1138 43 0.1483 
A 670 0.6250 328 0.6667 342 0.5897 
G 402 0.3750 164 0.3333 238 0.4103 
EH rs1799750 
1G1G 169 0.2721 65 0.2481 104 0.2897 
1G2G 309 0.4976 140 0.5334 169 0.4707 
2G2G 143 0.2303 57 0.2175 86 0.2396 
1G 647 0.5209 270 0.5153 377 0.5251 
2G 595 0.4791 254 0.4847 341 0.4749 
rs3918242 
СС 4 4 4 0.7150 189 0.7214 255 0.7103 
СТ 149 0.2399 64 0.2443 85 0.2368 
ТТ 28 0.0451 9 0.0343 19 0.0529 
С 1037 0.8349 442 0.8435 595 0.8287 
Т 205 0.1651 82 0.1565 123 0.1713 
rs17576 
AA 229 0.3688 100 0.3817 129 0.3593 
GA 311 0.5008 131 0.50 0 0 180 0.5014 
GG 81 0.1304 31 0.1183 50 0.1393 
A 769 0.6192 331 0.6317 438 0.6101 
G 473 0.3808 193 0.3683 280 0.3899 
Р U rs1799750 
1G1G 121 0.3033 45 0.2394 76 0.3602 
1G2G 195 0.4887 98 0.5212 97 0.4597 
2G2G 83 0.2080 45 0.2394 38 0.1801 
1G 437 0.5476 188 0.50 0 0 249 0.5901 
2G 361 0.4524 188 0.50 0 0 173 0.4099 
rs3918242 
СС 277 0.6942 129 0.6862 148 0.7014 
СТ 115 0.2883 58 0.3085 57 0.2701 
ТТ 7 0.0175 1 0.0053 6 0.0285 
С 669 0.8383 316 0.8404 353 0.8365 
Т 129 0.1617 60 0.1596 69 0.1635 
rs17576 
AA 142 0.3559 69 0.3670 73 0.3460 
GA 184 0.4612 83 0.4415 101 0.4787 
GG 73 0.1829 36 0.1915 37 0.1753 
A 468 0.5865 221 0.5878 247 0.5853 
G 330 0.4135 155 0.4122 175 0.4147 

























































Central Phenotype Association (significance) (associated allele) Reference 
rs1799750 MMP1 70/119 POAG OR = 1.64, р = 0.01 [1] 
POAG OR = 1.64, p = 0.002 [2] 
POAG OR = 1.34, р = 0,017 (2 G) [3] 
POAG OR = 2.04, р < 0,001 (2 G) [4] 
POAG OR = 1.35, p = 0.017 (2 G) [5] 
POAG p > 0.05 [6] 
peptic ulcer OR = 3.46, p = 0.03 (1 G/1 G) [7] 
gastric cancer OR = 3.34, р = 0.016 (2 G/2 G) [8] 
gastric cancer OR = 1.05, р = 0.013 (2 G) [9] 
IS with hypertension OR = 1.54, p = 0.005 (2 G) [10] 
IS with hypertension OR > 1; p < 0.05 (2 G) [11] 
IS with hypertension p > 0.05 [12–17] 
essential hypertension in men OR = 2.58; р = 0.04 (together with rs11568818, rs1320632, 
rs11225395) 
[18] 
essential hypertension in women p > 0.05 [19] 
rs3918242 MMP9 106/127 POAG OR = 1.63; р = 0.002 ( Т ) [20] 
POAG OR = 1.55, p = 0.012 (T) [5] 
POAG OR = 1.46, p = 0.032 (CT + TT) [21] 
POAG p > 0.05 [ 1 , 4 , 22 ] 
peptic ulcer p > 0.05 [7] 
gastric cancer OR = 2.60; р < 0.05 (together with rs17576 and rs17577) [23] 
esophageal cancer OR = 2.71; р = 0.02 ( СС ) [24] 
gastric cancer p > 0.05 [25] 
IS with hypertension OR = 2,76; р = 0.003 ( Т T) [26] 
IS with hypertension OR = 1,73; р < 0,05 ( Т ) [27] 
IS with hypertension OR = 2,20; р < 0,05 ( ТТ ) [28] 
IS with hypertension OR = 2,08; р = 0,016 ( Т ) [29] 
IS with hypertension OR < 1; р = 0.001 (CC) [30] 


















































Table 2 ( continued ) 




Phenotype Association (significance) (associated allele) Reference 
IS with hypertension OR > 1; р = 0.009 (T) [31] 
IS with hypertension OR = 5,53; р = 0,001 ( СС ) [32] 
IS with hypertension OR = 1.43; р = 0.001 ( Т ) [33] 
IS with hypertension OR = 5.47; р < 0.05 (T Т ) [34] 
IS with hypertension OR = 1.27; р = 0.01 (T) [12] 
IS with hypertension p > 0.05 [35] 
essential hypertension OR = 1.30; р = 0.002 [36] 
isolated systolic hypertension OR > 1; р = 0,009 (T) [37] 
left ventricular hypertrophy in 
hypertensive patients 
OR > 1; р = 0,0015 (together with rs2234681 and rs17576) [38] 
hypertension of pregnancy OR < 1; р = 0,007 ( СС ) [39] 
essential hypertension in children OR > 1; р < 0.05 ( ТТ ) [40] 
essential hypertension p > 0.05 [41] 
rs17576 MMP9 78/97 POAG OR = 1.96; р = 0.0 0 05 (AG) [20] 
POAG OR = 0.66; p = 0.03 (A) [21] 
POAG OR = 1.53; p = 0.034 (GG) [42] 
POAG in men OR = 0.56; р = 0,003 (together with rs2250889) [43] 
POAG OR = 2.34; p = 0.01 (GG) [4] 
POAG p > 0.05 [6] 
peptic ulcer OR = 0.49; p = 0.007 (AA) [7] 
gastric cancer OR = 4.34; р < 0.05 (Q) [23] 
gastric cancer p > 0.05 [44] 
IS with hypertension OR = 0,91; р = 0,04 (GG) [45] 
IS with hypertension p > 0.05 
[ 15 , 26 , 29 , 30 , 31 ] 
left ventricular hypertrophy in 
hypertensive patients 
OR > 1; р = 0,0015 (together with rs2234681 and rs3918242) [38] 
essential hypertension OR > 1; р < 0.05 ( АА) [41] 
isolated systolic hypertension p > 0.05 [37] 















































































































( β) P-Value Tissue 
11 rs1799750 TC T MMP1 −0.66 9.6E-84 Cells - Cultured fibroblasts 
MMP1 −0.52 1.3E-25 Thyroid 
MMP1 −0.42 1.9E-25 Lung 
MMP1 −0.58 5.8E-23 Heart - Atrial Appendage 
MMP1 −0.45 0.0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 017 Adipose - Visceral (Omentum) 
MMP1 −0.46 0.0 0 0 0 0 0 0 0 0 0 0 0 0 066 Heart - Left Ventricle 
MMP1 −0.36 0.0 0 0 0 0 0 0 0 0 022 Nerve - Tibial 
MMP1 −0.32 0.0 0 0 0 0 0 013 Esophagus - Muscularis 
MMP1 −0.35 0.0 0 0 0 0 0 015 Artery - Aorta 
MMP1 −0.28 0.0 0 0 0 0 0 024 Adipose - Subcutaneous 
MMP1 −0.22 0.0 0 0 0 0 038 Artery - Tibial 
MMP10 −0.19 0.0 0 0 0 025 Lung 
MMP1 −0.3 0.0 0 0 0 028 Esophagus - Gastroesophageal Junction 
MMP1 −0.28 0.0 0 0 0 075 Breast - Mammary Tissue 
WTAPP1 −0.15 0.0 0 0 04 Testis 
20 rs3918242 C T SLC12A5 0.61 0.0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 059 Lung 
SLC12A5 0.8 0.0 0 0 0 0 0 0 0 0 0 0 0 0 016 Adipose - Visceral (Omentum) 
SLC12A5 0.6 0.0 0 0 0 0 0 0 0 0 045 Adipose - Subcutaneous 
SLC12A5 0.69 0.0 0 0 0 0 0 045 Breast - Mammary Tissue 
SLC12A5 0.63 0.0 0 0 0 0 0 082 Artery - Aorta 
SLC12A5 0.78 0.0 0 0 0 0 018 Spleen 
SLC12A5 −0.61 0.0 0 0 0 0 019 Adrenal Gland 
SNX21 0.21 0.0 0 0 0 0 099 Muscle - Skeletal 
SLC12A5 0.45 0.0 0 0 0 029 Thyroid 
SLC12A5 0.43 0.0 0 0 0 037 Nerve - Tibial 
SLC12A5 0.43 0.0 0 0 0 038 Uterus 


















































Table 4 ( continued ) 









SLC12A5 0.41 0.0 0 0 0 053 Skin - Sun Exposed (Lower leg) 
SLC12A5 0.48 0.0 0 0 01 Skin - Not Sun Exposed (Suprapubic) 
PLTP −0.25 0.0 0 0 028 Nerve - Tibial 
20 rs17576 A G SLC12A5 −0.57 0.0 0 0 0 0 0 0 0 0 0 043 Adrenal Gland 
PLTP −0.26 0.0 0 0 0 0 0 0 0 033 Lung 
PLTP −0.32 0.0 0 0 0 0 0 026 Heart - Left Ventricle 
PLTP −0.24 0.0 0 0 0 0 0 034 Nerve - Tibial 
PLTP −0.2 0.0 0 0 0 0 021 Adipose - Subcutaneous 
NEURL2 −0.3 0.0 0 0 0 0 026 Adipose - Visceral (Omentum) 
PLTP −0.2 0.0 0 0 0 0 046 Thyroid 
PLTP −0.19 0.0 0 0 0 0 055 Artery - Tibial 
PLTP −0.37 0.0 0 0 0 0 066 Adrenal Gland 
NEURL2 −0.24 0.0 0 0 0 015 Adipose - Subcutaneous 
PLTP −0.25 0.0 0 0 0 02 Artery - Aorta 
NEURL2 −0.31 0.0 0 0 0 021 Artery - Aorta 
PLTP −0.18 0.0 0 0 0 024 Adipose - Visceral (Omentum) 
PLTP −0.3 0.0 0 0 0 025 Colon - Sigmoid 
PLTP −0.22 0.0 0 0 0 033 Brain - Frontal Cortex (BA9) 
PCIF1 0.35 0.0 0 0 0 041 Adrenal Gland 
ZSWIM1 −0.26 0.0 0 0 0 068 Adipose - Visceral (Omentum) 
RP3–
337O18.9 
−0.22 0.0 0 0 0 076 Lung 
PLTP −0.32 0.0 0 0 0 091 Pituitary 
SNX21 0.14 0.0 0 0 012 Muscle - Skeletal 
RP3–
337O18.9 
−0.2 0.0 0 0 028 Adipose - Subcutaneous 
NEURL2 −0.22 0.0 0 0 036 Lung 



















































The sQTL values of the 3 SNPs of the MMP genes. (according to Genotype-Tissue Expression (GTEx) ( http://www.gtexportal.org/ )). 
Chr SNP Reference allele Alternative allele Gene Symbol Intron Id Effect Size ( β) P-Value Tissue 
11 rs1799750 TC T WTAPP1 102,832,906:102,833,452:clu_16,168 −0.51 0.0 0 0 0 0 0 0 0 0 065 Testis 
20 rs3918242 C T CD40 46,126,741:46,128,138:clu_33,045 0.5 0.0 0 0 0 0 0 0 029 Thyroid 
CD40 46,126,741:46,128,138:clu_32,508 0.45 0.0 0 0 0 0 0 0 067 Lung 
CD40 46,126,741:46,128,138:clu_32,508 0.45 0.0 0 0 0 0 0 0 067 Lung 
SLC12A5 46,021,886:46,023,369:clu_29,529 0.79 0.0 0 0 0 0 0 0 098 Pituitary 
CD40 46,126,741:46,128,138:clu_27,442 0.49 0.0 0 0 0 0 041 Artery - Aorta 
ACOT8 45,841,956:45,844,263:clu_24,540 0.58 0.0 0 0 0 011 Heart - Left Ventricle 
CD40 46,126,741:46,128,138:clu_22,055 0.74 0.0 0 0 0 015 Cells - EBV-transformed lymphocytes 
ACOT8 45,841,956:45,844,263:clu_27,123 0.49 0.0 0 0 0 041 Heart - Atrial Appendage 
20 rs17576 A G SLC12A5 46,021,886:46,023,369:clu_29,529 0.63 0.0 0 0 0 0 0 0 0 0 0 093 Pituitary 
SLC12A5 46,023,071:46,023,369:clu_24,852 −0.45 0.0 0 0 0 0 033 Brain - Cortex 
SLC12A5 46,021,886:46,023,369:clu_26,648 0.46 0.0 0 0 0 02 Brain - Cerebellum 
SLC12A5 46,021,886:46,023,369:clu_53,353 0.38 0.0 0 0 011 Testis 









































examined at the Department of Eye Microsurgery (patients with POAG), Department of Cardiol-
gy (patients with EH), and Department of Gastroenterology (patients with PU) of St. Iasaf Bel-
orod Regional Clinical Hospital. All participants were self-reported unrelated Russians born in
entral Russia [46] . The study was approved by the Regional Ethics Committee of Belgorod State
niversity. All participants signed an informed consent prior to the enrolment to this study. 
.2. DNA analysis 
Phlebotomy was performed by a certified nurse. Blood (5 ml) was drawn from the ulnar
ein to a plastic vial (Vacutainer R ©) with 0.5 M EDTA ( рН= 8.0). Total genomic DNA was iso-
ated from the buffy coat by the standard phenol-chloroform protocol [47] and then checked
or quality using Nanodrop 20 0 0 spectrophotometer (Thermo Scientific, Inc.). Only samples with
260/ А280 = 1.7–2.0 were used for the analysis. The isolated DNA was stored at −80 °С . 
Three SNPs of the MMP genes (rs1799750 MMP1 , rs3918242 and rs17576 MMP9 ) were se-
ected for the analysis. The following selection criteria were applied [ 4 8 , 4 9 ]: 1) Previously re-
orted associations with POAG, EH and PU ( Table 2 ), 2) Regulatory potential (regSNP) ( Table 3 ),
) Effect on gene expression (eSNP) ( Table 4 ), 4) Splicing QTLs (sSNP) ( Table 5 ), and 5) MAF >
%. 
The selected loci were associated with POAG, EH and PU in previously published candidate
ene association studies ( Table 2 ) and have functional significance: significant regulatory poten-
ial ( Table 3 ) (determined using the online tools HaploReg, v4.1 update 05.11.2015, https://pubs.
roadinstitute.org/mammals/haploreg/haploreg.php ), influence gene expression level ( Table 4 )
nd involved in splicing QTLs ( Table 5 ) (determined using the GTExportal data, http://www.
texportal.org/ ). 
The DNA samples used for the analysis had concentration 10–15 ng/ml. A single well iPLEX
NP genotyping assay was designed using the Assay Design Suite 1.0 ( http://agenabio.com/
ssay- design- suite- 10- software ). For this purpose, three SNPs of interest were retrieved from
bSNP of NCBI and imported into the software according to their IDs. DNA genotyping was per-
ormed on the MALDI-TOF mass spectrometry iPLEX platform (Agena Bioscience Inc, San Diego,
A). 
For quality control of genotyping, 5% of blind replicate samples were included. The concor-
ance for replicate samples was 100%. 
.3. Statistical analysis 
The studied SNPs were checked for their correspondence to the Hardy-Weinberg equilibrium
HWE) using the chi-square test. The frequencies of alleles and genotypes were analyzed for
ossible differences between the females and males in the study sample using the Kruskall-
allis test. 
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Supplementary material associated with this article can be found, in the online version, at
doi: 10.1016/j.dib.2020.106004 . 
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